Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | FH-STEAP1 IL-18 CAR-T cells |
| Synonyms | |
| Therapy Description |
FH-STEAP1 IL-18 CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) targeting STEAP1 and to express IL-18, which potentially induce antitumor immune response and inhibit tumor growth (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| FH-STEAP1 IL-18 CAR-T cells | FH-STEAP1 IL-18 CAR T-cells|Anti-STEAP1/IL-18 CAR T-cells | FH-STEAP1 IL-18 CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) targeting STEAP1 and to express IL-18, which potentially induce antitumor immune response and inhibit tumor growth (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07803653 | Phase I | FH-STEAP1 IL-18 CAR-T cells Cyclophosphamide + Fludarabine | IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer | Not yet recruiting | USA | 0 |